A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 9, Issue , 2007, Pages

  Gourraud, Pierre Antoine ^a   Dieudé, Philippe ^b   Boyer, Jean Frédéric ^c   Nogueira, Leonor ^d   Cambon Thomsen, Anne ^f   Mazières, Bernard ^c   Cornélis, François ^e   Serre, Guy ^d   Cantagrel, Alain ^c   Constantin, Arnaud ^a,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c CHU RANGUEIL   (France)

^d CHU PURPAN   (France)

^e Parc Scientifique de Luminy   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; ASPARTIC ACID; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; FIBRIN ANTIBODY; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HLA DR ANTIGEN; LEUCINE; LYSINE; RHEUMATOID FACTOR; VALINE; BIOLOGICAL MARKER; HLA-DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; ANTIBODY PRODUCTION; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FRANCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; BLOOD; CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; MIDDLE AGED;

ALLELES; ANTIBODY FORMATION; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RHEUMATOID FACTOR;

EID: 34047200804     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2131     Document Type: Article

References (46)

1. El-Gabalawy HS Duray P Goldbach-Mansky R Evaluating patients with arthritis of recent onset: Studies in pathogenesis and prognosis JAMA 2000 284 2368-2373 10.1001/jama.284.18.2368 11066188
2. Scott DL The diagnosis and prognosis of early arthritis: Rationale for new prognostic criteria Arthritis Rheum 2002 46 286-290 10.1002/ art.10134 11840430
3. Girbal-Neuhauser E Durieux JJ Arnaud M Dalbon P Sebbag M Vincent C Simon M Senshu T Masson-Bessiere C Jolivet-Reynaud C The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues J Immunol 1999 162 585-594 9886436
4. Schellekens GA de Jong BA van den Hoogen FH van de Putte LB van Venrooij WJ Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J Clin Invest 1998 101 273-281 508564 9421490
5. Nienhuis RL Mandema E A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor Ann Rheum Dis 1964 23 302-305 1030930 14178016
6. Young A Jaraquemada D Awad J Festenstein H Corbett M Hay FC Roitt IM Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities Arthritis Rheum 1984 27 20-25 10.1002/art.1780270104 6197976
7. Simon M Girbal E Sebbag M Gomes-Daudrix V Vincent C Salama G Serre G The cytokeratin filament-aggregating protein filaggrin is the target of the so-called 'antikeratin antibodies,' autoantibodies specific for rheumatoid arthritis J Clin Invest 1993 92 1387-1393 288281 7690781
8. Schellekens GA Visser H de Jong BA van den Hoogen FH Hazes JM Breedveld FC van Venrooij WJ The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum 2000 43 155-163 10.1002/ 1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3 10643712
9. Auger I Sebbag M Vincent C Balandraud N Guis S Nogueira L Svensson B Cantagrel A Serre G Roudier J Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen Arthritis Rheum 2005 52 3424-3432 10.1002/ art.21391 16255019
10. Chapuy-Regaud S Nogueira L Clavel C Sebbag M Vincent C Serre G IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin Clin Exp Immunol 2005 139 542-550 10.1111/j.1365-2249.2004.02708.x 15730401
11. Masson-Bessiere C Sebbag M Girbal-Neuhauser E Nogueira L Vincent C Senshu T Serre G The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin J Immunol 2001 166 4177-4184 11238669
12. Berglin E Padyukov L Sundin U Hallmans G Stenlund H Van Venrooij WJ Klareskog L Dahlqvist SR A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis Arthritis Res Ther 2004 6 R303-R308 464874 15225365 10.1186/ar1187
13. Nielen MM van Schaardenburg D Reesink HW van de Stadt RJ van der Horst-Bruinsma IE de Koning MH Habibuw MR Vandenbroucke JP Dijkmans BA Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors Arthritis Rheum 2004 50 380-386 10.1002/art.20018 14872479
14. van Gaalen FA Linn-Rasker SP van Venrooij WJ de Jong BA Breedveld FC Verweij CL Toes RE Huizinga TW Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study Arthritis Rheum 2004 50 709-715 10.1002/art.20044 15022309
15. Visser H le Cessie S Vos K Breedveld FC Hazes JM How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis Arthritis Rheum 2002 46 357-365 10.1002/art.10117 11840437
16. von Essen R Kurki P Isomaki H Okubo S Kautiainen H Aho K Prospect for an additional laboratory criterion for rheumatoid arthritis Scand J Rheumatol 1993 22 267-272 7505480
17. Jansen AL van der Horst-Bruinsma I van Schaardenburg D van de Stadt RJ de Koning MH Dijkmans BA Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis J Rheumatol 2002 29 2074-2076 12375314
18. Kroot EJ de Jong BA van Leeuwen MA Swinkels H van den Hoogen FH van't Hof M van de Putte LB van Rijswijk MH van Venrooij WJ van Riel PL The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis Rheum 2000 43 1831-1835 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6 10943873
19. Vincent C Nogueira L Sebbag M Chapuy-Regaud S Arnaud M Letourneur O Rolland D Fournie B Cantagrel A Jolivet M Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: A highly effective test for the diagnosis of rheumatoid arthritis Arthritis Rheum 2002 46 2051-2058 10.1002/art.10436 12209508
20. Meyer O Labarre C Dougados M Goupille P Cantagrel A Dubois A Nicaise-Roland P Sibilia J Combe B Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Ann Rheum Dis 2003 62 120-126 1754441 12525380 10.1136/ard.62.2.120
21. Paimela L Gripenberg M Kurki P Leirisalo-Repo M Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis Ann Rheum Dis 1992 51 743-746 1004738 1377463
22. van Jaarsveld CH ter Borg EJ Jacobs JW Schellekens GA Gmelig-Meyling FH van Booma-Frankfort C de Jong BA van Venrooij WJ Bijlsma JW The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis Clin Exp Rheumatol 1999 17 689-697 10609067
23. Vencovsky J Machacek S Sedova L Kafkova J Gatterova J Pesakova V Ruzickova S Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis Ann Rheum Dis 2003 62 427-430 1754544 12695154 10.1136/ard.62.5.427
24. van der Helm-van Mil AH Verpoort KN Breedveld FC Huizinga TW Toes RE de Vries RR The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis Arthritis Rheum 2006 54 1117-1121 10.1002/art.21739 16572446
25. Newton JL Harney SM Wordsworth BP Brown MA A review of the MHC genetics of rheumatoid arthritis Genes Immun 2004 5 151-157 10.1038/ sj.gene.6364045 14749714
26. Seldin MF Amos CI Ward R Gregersen PK The genetics revolution and the assault on rheumatoid arthritis Arthritis Rheum 1999 42 1071-1079 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8 10366098
27. Stastny P Mixed lymphocyte cultures in rheumatoid arthritis J Clin Invest 1976 57 1148-1157 436767 1262462
28. Gregersen PK Silver J Winchester RJ The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis Arthritis Rheum 1987 30 1205-1213 10.1002/ art.1780301102 2446635
29. Gorman JD Lum RF Chen JJ Suarez-Almazor ME Thomson G Criswell LA Impact of shared epitope genotype and ethnicity on erosive disease: A meta-analysis of 3,240 rheumatoid arthritis patients Arthritis Rheum 2004 50 400-412 10.1002/art.20006 14872482
30. van Gaalen FA van Aken J Huizinga TW Schreuder GM Breedveld FC Zanelli E van Venrooij WJ Verweij CL Toes RE de Vries RR Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis Arthritis Rheum 2004 50 2113-2121 10.1002/art.20316 15248208
31. Hoppe B Haupl T Gruber R Kiesewetter H Burmester GR Salama A Dorner T Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: A case-control study Arthritis Res Ther 2006 8 R34 1526594 16469113 10.1186/ar1889
32. Irigoyen P Lee AT Wener MH Li W Kern M Batliwalla F Lum RF Massarotti E Weisman M Bombardier C Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA-DR3 and the shared epitope alleles Arthritis Rheum 2005 52 3813-3818 10.1002/ art.21419 16320316
33. de Vries N Tijssen H van Riel PL van de Putte LB Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule Arthritis Rheum 2002 46 921-928 10.1002/art.10210 11953968
34. Reviron D Perdriger A Toussirot E Wendling D Balandraud N Guis S Semana G Tiberghien P Mercier P Roudier J Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis Arthritis Rheum 2001 44 535-540 10.1002/ 1529-0131(200103)44:3<535::AID-ANR101>3.0.CO;2-Z 11263767
35. du Montcel ST Michou L Petit-Teixeira E Osorio J Lemaire I Lasbleiz S Pierlot C Quillet P Bardin T Prum B New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility Arthritis Rheum 2005 52 1063-1068 10.1002/art.20989 15818663
36. Gourraud PA Boyer JF Barnetche T Abbal M Cambon-Thomsen A Cantagrel A Constantin A A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity Arthritis Rheum 2006 54 593-599 10.1002/art.21630 16447236
37. Michou L Croiseau P Petit-Teixeira E du Montcel ST Lemaire I Pierlot C Osorio J Frigui W Lasbleiz S Quillet P Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis Arthritis Res Ther 2006 8 R79 1526640 16646982 10.1186/ar1949
38. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988 31 315-324 10.1002/art.1780310302 3358796
39. Zanelli E Breedveld FC de Vries RR HLA class II association with rheumatoid arthritis: Facts and interpretations Hum Immunol 2000 61 1254-1261 10.1016/S0198-8859(00)00185-3 11163080
40. Forslind K Ahlmen M Eberhardt K Hafstrom I Svensson B Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) Ann Rheum Dis 2004 63 1090-1095 10.1136/ard.2003.014233 15308518
41. Huizinga TW Amos CI van der Helm-van Mil AH Chen W van Gaalen FA Jawaheer D Schreuder GM Wener M Breedveld FC Ahmad N Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins Arthritis Rheum 2005 52 3433-3438 10.1002/art.21385 16255021
42. Bas S Perneger TV Mikhnevitch E Seitz M Tiercy JM Roux-Lombard P Guerne PA Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis Rheumatology (Oxford) 2000 39 1082-1088 10.1093/rheumatology/39.10.1082 11035127
43. Boki KA Kurki P Holthofer H Tzioufas AG Drosos AA Moutsopoulos HM Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study J Rheumatol 1995 22 2046-2048 8596142
44. Goldbach-Mansky R Lee J McCoy A Hoxworth J Yarboro C Smolen JS Steiner G Rosen A Zhang C Menard HA Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset Arthritis Res 2000 2 236-243 17811 11056669 10.1186/ar93
45. Verpoort KN van Gaalen FA van der Helm-van Mil AH Schreuder GM Breedveld FC Huizinga TW de Vries RR Toes RE Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis Arthritis Rheum 2005 52 3058-3062 10.1002/art.21302 16200610
46. Hill JA Southwood S Sette A Jevnikar AM Bell DA Cairns E Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule J Immunol 2003 171 538-541 12847215